Buprenorphine 00093-3656
Product NDC
00093-3656- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- November 26, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA204937
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 5 ug/h |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
4 POUCH in 1 CARTON (0093-3656-40) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH